EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors”

Advanced Science · 2026-06 · 13 (36)

DOI: 10.1002/advs.75743 ↗

Kurz gefasst

Korrektur in der Zeitschrift Advanced Science, online erschienen am 20.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors”. Advanced Science, 13(36). https://doi.org/10.1002/advs.75743

Vancouver

Correction to “Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors”. Advanced Science. 2026;13(36). doi:10.1002/advs.75743

BibTeX
@article{euvimed2026,
  title = {Correction to “Pro‐ATO/Allicin Liposomes for Dual‐Pathway Targeting of p53‐Mutant Tumors”},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {36},
  doi = {10.1002/advs.75743}
}
Kostenlos starten →